全文获取类型
收费全文 | 2262篇 |
免费 | 154篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 116篇 |
妇产科学 | 50篇 |
基础医学 | 258篇 |
口腔科学 | 19篇 |
临床医学 | 289篇 |
内科学 | 479篇 |
皮肤病学 | 18篇 |
神经病学 | 239篇 |
特种医学 | 49篇 |
外科学 | 222篇 |
综合类 | 22篇 |
预防医学 | 284篇 |
眼科学 | 65篇 |
药学 | 166篇 |
肿瘤学 | 131篇 |
出版年
2024年 | 5篇 |
2023年 | 27篇 |
2022年 | 38篇 |
2021年 | 69篇 |
2020年 | 49篇 |
2019年 | 70篇 |
2018年 | 83篇 |
2017年 | 51篇 |
2016年 | 51篇 |
2015年 | 64篇 |
2014年 | 101篇 |
2013年 | 106篇 |
2012年 | 171篇 |
2011年 | 222篇 |
2010年 | 109篇 |
2009年 | 89篇 |
2008年 | 140篇 |
2007年 | 155篇 |
2006年 | 155篇 |
2005年 | 141篇 |
2004年 | 120篇 |
2003年 | 118篇 |
2002年 | 130篇 |
2001年 | 17篇 |
2000年 | 14篇 |
1999年 | 15篇 |
1998年 | 23篇 |
1997年 | 20篇 |
1996年 | 14篇 |
1995年 | 11篇 |
1994年 | 5篇 |
1993年 | 8篇 |
1992年 | 4篇 |
1991年 | 4篇 |
1990年 | 3篇 |
1988年 | 2篇 |
1987年 | 3篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 1篇 |
1980年 | 3篇 |
1979年 | 3篇 |
排序方式: 共有2419条查询结果,搜索用时 15 毫秒
1.
Many important pharmaceutical agents, including vancomycin, bleomycin, cyclosporin, and several antibiotics, are produced by non‐ribosomal peptide synthetase (NRPS) enzymes in microorganisms. The NRPS pathway produces an extensive library of products using multienzyme complexes acting in an assembly‐line fashion. Engineering an NRPS system to produce an even greater variety of products, some of which may also have beneficial therapeutic value, would be an enormous advantage. Several approaches have been successful in generating novel NRPS products: mutational biosynthesis during which nonnatural substrates are fed to an organism; domain and module swapping between different species to generate hybrid enzymes; and rational site‐directed mutagenesis, based either on phylogeny or computational prediction, intended to switch substrate specificity and produce altered products. This review will highlight the progress in these areas and describe research in the future that will extend the capacity for re‐engineering NRPS systems. Drug Dev. Res. 66:9–18, 2006. © 2006 Wiley‐Liss, Inc. 相似文献
2.
Spencer Moore Cynthia Smith Tammy Simpson Sharlene Wolbeck Minke 《BMC health services research》2006,6(1):141
Background
Knowledge of the structure and character of inter-organizational relationships found among health promotion organizations is a prerequisite for the development of evidence-based network-level intervention activities. The Alberta Healthy Living Network (AHLN) mapped the inter-organizational structure of its members to examine the effects of the network environment on organizational-level perceptions. This exploratory analysis examines whether network structure, specifically partnership ties among AHLN members, influences organizational perceptions of support after controlling for organizational-level attributes. 相似文献3.
4.
5.
Role of substance P in several models of bladder inflammation 总被引:1,自引:0,他引:1
Judith Luber-Narod Tammy Austin-Ritchie Carl Hollins III Mani Menon Rajwant K. Malhotra Stephen Baker Robert E. Carraway 《Urological research》1997,25(6):395-399
Substance P (SP) is a peptide found in the sensory nervous system which has multiple biologic effects including stimulation of muscle contraction, pain nociception, immune cell functions, plasma extravasation and a constellation of inflammatory effects. Here we investigate the role of SP in several animals models of bladder inflammation. Using the female Lewis rat, inflammation was induced using either xylene, lipopolysaccharide (LPS) or polyinosinic-polycytidylic acid (polyIC). Inflammation occurred rapidly (4 h) and was maintained in each model for at least 7 days. Each of these protocols decreased the bladder content of immunoreactive SP by approximately 50%, suggesting enhanced release. There was no change in the urinary frequency of these animals over 3 weeks, suggesting that urinary frequency changes are not mediated by acute inflammation. We also found that the SP receptor (NK1) antagonist, (?)CP96345, was unable to block the inflammation produced by polyIC, suggesting that SP is not an obligatory mediator of immune cell stimulation in this model. 相似文献
6.
7.
8.
9.
10.
Bryce A. Kiberd Tammy Keough-Ryan Catherine M. Clase 《American journal of transplantation》2003,3(5):619-625
American Society of Transplantation guidelines recommend screening renal transplant recipients for breast, colorectal and prostate cancer. However there is a lack of evidence to support this practice. Computer simulation modeling was used to estimate the years of life lost as a result of these cancers in 50-year-old renal transplant recipients and subjects in the general population. Renal transplant recipients lost fewer years of life to cancer than people in the general population largely because of reduced life expectancy. In nondiabetic transplant recipients, loss of life as a result of these cancers was comparable with that in the general population only under assumptions of increased cancer incidence and cancer-specific mortality risks. Even with two-fold higher cancer incidence and disease-specific mortality risks, diabetic transplant recipients lost considerably fewer life years to cancer than those in the general population. Recommended cancer screening for the general population may not yield the expected benefits in the average renal transplant recipient but the benefits will be considerably higher than for patients on dialysis. Transplanted patients at above-average cancer risk in good health may achieve the benefits of screening that are seen in the general population. 相似文献